BCAT1 and colorectal carcinoma: In a case-control study involving 218 individuals, the combined analysis of IKZF1 and BCAT1 demonstrated a diagnostic sensitivity of 77% for CRC detection, with detection rates of 50% and 68% for stages I and II, respectively.